The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ABT US 10/18/19 P85 | Listed Option | 002824950 | 233 | 900 | SH | Put | SOLE | 900 | 0 | 0 | |
| ATRICURE INC | Equity | 04963C209 | 21,199 | 850,000 | SH | SOLE | 850,000 | 0 | 0 | ||
| BIO-RAD LABORATORIES-A | Equity | 090572207 | 38,265 | 115,000 | SH | SOLE | 115,000 | 0 | 0 | ||
| CANTEL MEDICAL CORP | Equity | 138098108 | 10,098 | 135,000 | SH | SOLE | 135,000 | 0 | 0 | ||
| CORREVIO PHARMA CORP | Equity | 22026V105 | 9,000 | 4,500,000 | SH | SOLE | 4,500,000 | 0 | 0 | ||
| QUEST DIAGNOSTICS INC | Equity | 74834L100 | 18,730 | 175,000 | SH | SOLE | 175,000 | 0 | 0 | ||
| GW PHARMACEUTICALS -ADR | Depository Receipt | 36197T103 | 2,876 | 25,000 | SH | SOLE | 25,000 | 0 | 0 | ||
| HMS HOLDINGS CORP | Equity | 40425J101 | 7,755 | 225,000 | SH | SOLE | 225,000 | 0 | 0 | ||
| HOLOGIC INC | Equity | 436440101 | 14,137 | 280,000 | SH | SOLE | 280,000 | 0 | 0 | ||
| ICU MEDICAL INC | Equity | 44930G107 | 5,586 | 35,000 | SH | SOLE | 35,000 | 0 | 0 | ||
| IVERIC BIO INC | Equity | 46583P102 | 3,360 | 3,000,000 | SH | SOLE | 3,000,000 | 0 | 0 | ||
| INTEGER HOLDINGS CORP | Equity | 45826H109 | 8,689 | 115,000 | SH | SOLE | 115,000 | 0 | 0 | ||
| IWM US 10/04/19 C155 | Listed Option | 464287905 | 33 | 3,000 | SH | Call | SOLE | 3,000 | 0 | 0 | |
| IWM US 10/18/19 C160 | Listed Option | 464287905 | 77 | 7,000 | SH | Call | SOLE | 7,000 | 0 | 0 | |
| LANTHEUS HOLDINGS INC | Equity | 516544103 | 18,799 | 750,000 | SH | SOLE | 750,000 | 0 | 0 | ||
| ALLSCRIPTS HEALTHCARE SOLUTI | Equity | 01988P108 | 46,391 | 4,225,000 | SH | SOLE | 4,225,000 | 0 | 0 | ||
| MDRX US 10/18/19 C10 | Listed Option | 01988P908 | 208 | 2,000 | SH | Call | SOLE | 2,000 | 0 | 0 | |
| MEDTRONIC PLC | Equity | 585055106 | 43,448 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
| MEDP US 12/20/19 P75 | Listed Option | 58506Q909 | 116 | 350 | SH | Put | SOLE | 350 | 0 | 0 | |
| NEVRO CORP | Equity | 64157F103 | 4,545 | 52,864 | SH | SOLE | 52,864 | 0 | 0 | ||
| OPTINOSE INC | Equity | 68404V100 | 4,725 | 675,000 | SH | SOLE | 675,000 | 0 | 0 | ||
| PACIRA BIOSCIENCES INC | Equity | 695127100 | 29,504 | 775,000 | SH | SOLE | 775,000 | 0 | 0 | ||
| PHREESIA INC | Equity | 71944F106 | 4,848 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
| PORTOLA PHARMACEUTICALS INC | Equity | 737010108 | 26,820 | 1,000,000 | SH | SOLE | 1,000,000 | 0 | 0 | ||
| RADNET INC | Equity | 750491102 | 4,667 | 325,000 | SH | SOLE | 325,000 | 0 | 0 | ||
| RIGEL PHARMACEUTICALS INC | Equity | 766559603 | 10,238 | 5,475,000 | SH | SOLE | 5,475,000 | 0 | 0 | ||
| SPY US 10/18/19 P290 | Listed Option | 78462F953 | 850 | 5,000 | SH | Put | SOLE | 5,000 | 0 | 0 | |
| STERICYCLE INC | Equity | 858912108 | 17,826 | 350,000 | SH | SOLE | 350,000 | 0 | 0 | ||
| STREAMLINE HEALTH SOLUTIONS | Equity | 86323X106 | 2,278 | 2,100,000 | SH | SOLE | 2,100,000 | 0 | 0 | ||
| UNITED THERAPEUTICS CORP | Equity | 91307C102 | 5,981 | 75,000 | SH | SOLE | 75,000 | 0 | 0 | ||
| XLV US 10/18/19 P90 | Listed Option | 81369Y959 | 540 | 5,000 | SH | Put | SOLE | 5,000 | 0 | 0 | |
| ZIMMER BIOMET HOLDINGS INC | Equity | 98956P102 | 21,963 | 160,000 | SH | SOLE | 160,000 | 0 | 0 | ||